Evaluation of methylation of MGMT (O6-methylguanine-dna methyltransferase) gene promoter in sporadic colorectal cancer

DNA and Cell Biology

Volumn 32, Issue 7, 2013, Pages 371-377

  Farzanehfar, Mohammadreza ^a   Vossoughinia, Hasan ^a   Jabini, Raheleh ^b   Tavassoli, Alireza ^a   Saadatnia, Hasan ^a   Khorashad, Ahmad Khosravi ^a   Ahadi, Mitra ^a   Afzalaghaee, Monavvar ^c   Ghayoor Karimiani, Ehsan ^b   Mirzaei, Farzaneh ^d   Ayatollahi, Hossein ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; COLON BIOPSY; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DNA REPAIR; EPIGENETICS; FEMALE; GENE INACTIVATION; GENETIC RISK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; QUANTITATIVE METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADULT; AGED; COLORECTAL NEOPLASMS; DNA; DNA METHYLATION; DNA REPAIR; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS, GENETIC;

EID: 84879903793     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1949     Document Type: Article

References (49)

1. An, Q., Liu, Y., Gao, Y., Huang, J., Fong, X., Li, L., Zhang, D., and Cheng, S. (2002). Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett 188, 109-114. (Pubitemid 35292336)
2. Belinsky, S.A., Liechty, K.C., Gentry, F.D., Wolf, H.J., Rogers, J., Vu, K., Haney, J., Kennedy, T.C., Hirsch, F.R., Miller, Y., Franklin, W.A., Herman, J.G., Baylin, S.B., Bunn, P.A., and Byers, T. (2006). Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk co-hort. Cancer Res 66, 3338-3344.
3. Candiloro, I.L., and Dobrovic, A. (2009). Detection of MGMT promoter methylation in normal individuals is strongly asso-ciated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res (Phila) 2, 862-867.
4. Cankovic, M., Mikkelsen, T., Rosenblum, M.L., and Zarbo, R.J. (2007). A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue. Lab Invest 87, 392-397. (Pubitemid 46474563)
5. Colella, S., Shen, L., Baggerly, K.A., Issa, J.P., and Krahe, R (2003). Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 35, 146-150. (Pubitemid 36828724)
6. Costello, J.F., Futscher, B.W., Tano, K., Graunke, D.M., and Pieper, R.O. (1994). Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem 269, 17228-17237. (Pubitemid 24204047)
7. Coulondre, C., and Miller, J.H. (1977). Genetic studies of the lac repressor. IV. Mutagenic specificity in the lacI gene of Es-cherichia coli. J Mol Biol 117, 577-606. (Pubitemid 8256693)
8. Day, R.S., 3rd, Ziolkowski, C.H., Scudiero, D.A., Meyer, SA., Lubiniecki, A.S., Girardi, A.J., Galloway, S.M., and Bynum, G.D. (1980). Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 288, 724-727. (Pubitemid 11168534)
9. Derks, S., Lentjes, M.H., Hellebrekers, D.M., de Bruine, A.P., Herman, J.G., and van Engeland, M. (2004). Methylation-specific PCR unraveled. Cell Oncol 26, 291-299. (Pubitemid 40916730)
10. Eads, C.A., Danenberg, K.D., Kawakami, K., Saltz, L.B., Blake, C., Shibata, D., Danenberg, P.V., and Laird, P.W. (2000). Me-thyLight: a high-throughput assay to measure DNA methyl-ation. Nucleic Acids Res 28, E32.
11. Erickson, L.C., Laurent, G., Sharkey, N.A., and Kohn, K.W. (1980). DNA cross-linking and monoadduct repair in ni-trosourea-treated human tumour cells. Nature 288, 727-729. (Pubitemid 11168535)
12. Esteller, M., Corn, P.G., Baylin, S.B., and Herman, J.G. (2001). A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229. (Pubitemid 32695003)
13. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, SN., Hidalgo, O.F., Vanaclocha, V., Baylin, S.B., and Herman, J.G (2000). Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343, 1350-1354.
14. Esteller, M., Hamilton, S.R., Burger, P.C., Baylin, S.B., and Herman, J.G. (1999). Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hyper-methylation is a common event in primary human neoplasia. Cancer Res 59, 793-797. (Pubitemid 29086728)
15. Fackler, M.J., McVeigh, M., Mehrotra, J., Blum, MA., Lange, J., Lapides, A., Garrett, E., Argani, P., and Sukumar, S. (2004). Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64, 4442-4452. (Pubitemid 38856915)
16. Fornace, A.J., Jr., Papathanasiou, M.A., Hollander, M.C., and Yarosh, D.B. (1990). Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER-human tumor cells. Cancer Res 50, 7908-7911.
17. Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., Molloy, P.L., and Paul, C.L. (1992). A genomic sequencing protocol that yields a positive display of 5-me-thylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA89, 1827-1831.
18. Harden, S.V., Sanderson, H., Goodman, S.N., Partin, A.A., Walsh, P.C., Epstein, J.I., and Sidransky, D. (2003). Quantita-tive GSTP1 methylation and the detection of prostate adeno-carcinoma in sextant biopsies. J Natl Cancer Inst 95, 1634-1637. (Pubitemid 37455931)
19. Havik, A.B., Brandal, P., Honne, H., Dahlback, H.S., Scheie, D., Hektoen, M., Meling, T.R., Helseth, E., Heim, S., Lothe, R.A., and Lind, G.E. (2012). MGMT promoter methylation in glio-mas-assessment by pyrosequencing and quantitative methyl-ation-specific PCR. J Transl Med 10, 36.
20. Hawkins, N.J., Lee, J.H., Wong, J.J., Kwok, C.T., Ward, R.L., and Hitchins, M.P. (2009). MGMT methylation is associated pri-marily with the germline C < T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol 22, 1588-1599.
21. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D., and Baylin, S.B. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93, 9821-9826. (Pubitemid 26296693)
22. Hoque, M.O., Begum, S., Topaloglu, O., Chatterjee, A., Ro-senbaum, E., Van Criekinge, W., Westra, W.H., Schoenberg, M., Zahurak, M., Goodman, S.N., and Sidransky, D. (2006). Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 98, 996-1004. (Pubitemid 44288164)
23. Huang, T.H., Perry, M.R., and Laux, D.E. (1999). Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8, 459-470. (Pubitemid 29097334)
24. Issa, J.P. (2002). Epigenetic variation and human disease. J Nutr 132, 2388S-2392S.
25. Issa, J.P., Ottaviano, Y.L., Celano, P., Hamilton, S.R., Davidson, N.E., and Baylin, S.B. (1994). Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7, 536-540. (Pubitemid 24308343)
26. Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W.G., and Sidransky, D. (2001). Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and or-gan-confined prostate adenocarcinoma. J Natl Cancer Inst 93, 1747-1752. (Pubitemid 33130264)
27. Kahn, S.L., Ronnett, B.M., Gravitt, P.E., and Gustafson, K.S. (2008). Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Can-cer 114, 57-64. (Pubitemid 351304613)
28. Kaina, B., Ochs, K., Grosch, S., Fritz, G., Lips, J., Tomicic, M., Dunkern, T., and Christmann, M. (2001). BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 68, 41-54. (Pubitemid 33804651)
29. Kamimae, S., Yamamoto, E., Yamano, H.O., Nojima, M., Suzuki, H., Ashida, M., Hatahira, T., Sato, A., Kimura, T., Yoshikawa, K., Harada, T., Hayashi, S., Takamaru, H., Maruyama, R., Kai, M., Nishiwaki, M., Sugai, T., Sasaki, Y., Tokino, T., Shino-mura, Y., Imai, K., and Toyota, M. (2011). Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colo-rectal tumors. Cancer Prev Res (Phila) 4, 674-683.
30. Lo, Y.M., Wong, I.H., Zhang, J., Tein, M.S., Ng, M.H., and Hjelm, N.M. (1999). Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res 59, 3899-3903. (Pubitemid 29393548)
31. Mellai, M., Caldera, V., Annovazzi, L., Chio, A., Lanotte, M., Cassoni, P., Finocchiaro, G., and Schiffer, D. (2009). MGMT promoter hypermethylation in a series of 104 glioblastomas. Cancer Genomics Proteomics 6, 219-227.
32. Mikeska, T., Bock, C., El-Maarri, O., Hubner, A., Ehrentraut, D., Schramm, J., Felsberg, J., Kahl, P., Buttner, R., Pietsch, T., and Waha, A. (2007). Optimization of quantitative MGMT promoter methylation analysis using pyrosequen-cing and combined bisulfite restriction analysis. J Mol Diagn 9, 368-381. (Pubitemid 47305073)
33. Ogino, S., Odze, R.D., Kawasaki, T., Brahmandam, M., Kirkner, G.J., Laird, P.W., Loda, M., and Fuchs, C.S. (2006). Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colo-rectal carcinoma. Am J Surg Pathol 30, 1175-1183. (Pubitemid 44299351)
34. Pegg, A.E. (1990). Mammalian O6-alkylguanine-DNA alkyl-transferase: regulation and importance in response to alky-lating carcinogenic and therapeutic agents. Cancer Res 50, 6119-6129. (Pubitemid 20323662)
35. Pegg, A.E. (2000). Repair of O(6)-alkylguanine by alkyl-transferases. Mutat Res 462, 83-100.
36. Pieper, R.O., Futscher, B.W., Dong, Q., Ellis, T.M., and Erickson, L.C. (1990). Comparison of O-6-methylguanine DNA methyltransferase (MGMT) mRNA levels in Mer + and Merhuman tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun 2, 13-20. (Pubitemid 20255634)
37. Povey, A.C., Badawi, A.F., Cooper, D.P., Hall, C.N., Harrison, K.L., Jackson, P.E., Lees, N.P., O'Connor, P.J., and Margison, G.P. (2002). DNA alkylation and repair in the large bowel: animal and human studies. J Nutr 132, 3518S-3521S. (Pubitemid 35315830)
38. Prakash, P., Porwal, M., and Saxena, A. (2012). Colon cancer: general diagnostic and treatment. J Pharm Res 5, 355-359.
39. Qian, X., von Wronski, M.A., and Brent, T.P. (1995). Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppres-sion. Carcinogenesis 16, 1385-1390.
40. Qian, X.C., and Brent, T.P. (1997). Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res 57, 3672-3677. (Pubitemid 27381206)
41. Reesink-Peters, N., Wisman, G.B., Jeronimo, C., Tokumaru, C.Y., Cohen, Y., Dong, S.M., Klip, H.G., Buikema, H.J., Suurmeijer, A.J., Hollema, H., Boezen, H.M., Sidransky, D., and van der Zee, A.G. (2004). Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2, 289-295. (Pubitemid 39031078)
42. Schmiemann, V., Bocking, A., Kazimirek, M., Onofre, A.S., Gabbert, H.E., Kappes, R., Gerharz, C.D., and Grote, H.J. (2005). Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 11, 7728-7734. (Pubitemid 41611615)
43. Schuebel, K.E., Chen, W., Cope, L., Glockner, S.C., Suzuki, H., Yi, J.M., Chan, T.A., Van Neste, L., Van Criekinge, W., van den Bosch, S., van Engeland, M., Ting, A.H., Jair, K., Yu, W., Toyota, M., Imai, K., Ahuja, N., Herman, J.G., and Baylin, S.B. (2007). Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3, 1709-1723. (Pubitemid 47510263)
44. Shen, L., Kondo, Y., Rosner, G.L., Xiao, L., Hernandez, N.S., Vilaythong, J., Houlihan, P.S., Krouse, R.S., Prasad, A.R., Einspahr, J.G., Buckmeier, J., Alberts, D.S., Hamilton, S.R., and Issa, J.P. (2005). MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97, 1330-1338. (Pubitemid 41487800)
45. Singer-Sam, J., LeBon, J.M., Tanguay, R.L., and Riggs, A.D. (1990). A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res 18, 687. (Pubitemid 20064048)
46. van Engeland, M., Weijenberg, M.P., Roemen, G.M., Brink, M., de Bruine, A.P., Goldbohm, R A., van den Brandt, P.A., Baylin, S.B., de Goeij, A.F., and Herman, J.G. (2003). Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63, 3133-3137. (Pubitemid 36735864)
47. Villalva, C., Cortes, U., Wager, M., Tourani, J.M., Rivet, P., Marquant, C., Martin, S., Turhan, A.G., and Karayan-Tapon, L. (2012). O6-Methylguanine- methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is cor-related to temozolomide sensitivity under differentiation-promoting conditions. Int J Mol Sci 13, 6983-6994.
48. Vlassenbroeck, I., Califice, S., Diserens, A.C., Migliavacca, E., Straub, J., Di Stefano, I., Moreau, F., Hamou, M.F., Renard, I., Delorenzi, M., Flamion, B., DiGuiseppi, J., Bierau, K., and Hegi, M.E. (2008). Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma. J Mol Diagn 10, 332-337. (Pubitemid 352019119)
49. Watts, G.S., Pieper, R.O., Costello, J.F., Peng, Y.M., Dalton, W.S., and Futscher, B.W. (1997). Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 17, 5612-5619. (Pubitemid 27357657)